Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis
- 1 June 1987
- Vol. 22 (6) , 424-428
- https://doi.org/10.1007/bf02537273
Abstract
Patients with cystic fibrosis (CF) and pancreatic insufficiency usually have decreased linoleic and increased oleic, palmitoleic and eicosatrienoic (20∶3ω9) acids compared to normal values of blood and tissue lipids. These changes are consistent with early essential fatty acid deficiency and are observed despite the regular use of exogenous pancreatic enzyme supplementation. As part of a study to determine the relative role of malabsorption as the etiology for the altered fatty acid status, the change in total plasma fatty acids and in area percent of plasma linoleic acid was determined in CF patients and control subjects following the ingestion of various lipid supplements, including two safflower oil preparations and two structured lipid preparations. Fasting subjects consumed 33 g of lipid in a milkshake containing 15 g of protein and 45 g of carbohydrate. Plasma samples obtained 0, 2, 4, 6 and 8 hr after the meal showed that the CF patients absorbed all preparations when administered with their regular dose of pancreatic enzyme supplement. Comparison of the patterns of increase for total plasma fatty acids and area percent of plasma linoleic acid following the administration of the different lipid supplements in CF patients and control subjects suggests that(a) malabsorption alone is not the cause of the abnormal fatty acid composition in the lipids of CF patients and that increased caloric intake along with consumption of adequate amounts of linoleic acid should improve the linoleic acid status of CF patients; (b) there may be selectively increased metabolism of certain fatty acids from the ingested lipids in the relatively malnourished CF patient compared to control subjects; and (c) conditions favoring the persistence of nonpancreatic lipases seem also to favor absorption and utilization of the structured lipid preparation containing medium chain length fatty acids and linoleic acid in CF patients compared to control subjects.This publication has 44 references indexed in Scilit:
- Secretion of human gastric lipase from dispersed gastric glandsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Linoleic Acid Absorption from Lipid Supplements in Patients with Cystic Fibrosis with Pancreatic Insufficiency and in Control SubjectsJournal of Pediatric Gastroenterology and Nutrition, 1985
- Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorptionThe Journal of Pediatrics, 1982
- Linoleic Acid Absorption in Children with Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1982
- Oral Correction of Essential Fatty Acid Deficiency in Cystic FibrosisJournal of Parenteral and Enteral Nutrition, 1981
- Fat Digestion in the NewbornJournal of Clinical Investigation, 1981
- Cystic fibrosis and malnutritionThe Journal of Pediatrics, 1979
- ABNORMAL LEVELS OF PROSTAGLANDINS AND FATTY ACIDS IN BLOOD OF CHILDREN WITH CYSTIC FIBROSISThe Lancet, 1978
- A new prognostic score and clinical evaluation system for cystic fibrosisThe Journal of Pediatrics, 1973
- Essential fatty acid deficiencyProgress in the Chemistry of Fats and other Lipids, 1971